What are the 10 rarest cardiovascular diseases?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

The 10 Rarest Cardiovascular Diseases

The rarest cardiovascular diseases are inherited arrhythmogenic conditions and specific cardiomyopathies with prevalence below 1:2,000 to 1:10,000 in the general population. Based on the available evidence, these conditions represent the most uncommon yet clinically significant cardiovascular disorders.

Inherited Arrhythmogenic Diseases (Prevalence <5 in 10,000)

The ACC/AHA/ESC guidelines explicitly classify several inherited conditions as rare diseases by European Parliament definition (prevalence below 5 in 10,000) 1:

1. Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

  • Estimated prevalence below 5 in 10,000 1
  • Characterized by exercise-induced ventricular arrhythmias in structurally normal hearts 1
  • VT induced by exercise stress testing represents the severe phenotype 1

2. Brugada Syndrome

  • Prevalence below 5 in 10,000 1
  • Spontaneous ST-segment elevation in right precordial leads indicates severe phenotype and increased sudden cardiac death risk 1
  • Genetically determined susceptibility to ventricular tachycardia without structural heart abnormalities 1

3. Short QT Syndrome

  • Prevalence below 5 in 10,000 1
  • Heritable channelopathy with potentially lethal arrhythmias 1
  • Represents one of the rarest ion channel disorders 1

Rare Cardiomyopathies

4. Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

  • Estimated prevalence 1:2,000 to 1:5,000 2, 3
  • Progressive dystrophy of ventricular myocardium with fibro-fatty replacement 2
  • Desmosomal gene mutations found in approximately 50% of cases 1, 2
  • 10% of deaths occur before age 19, and 50% before age 35 3

5. Left Ventricular Non-Compaction Cardiomyopathy

  • Rare heritable cardiomyopathy with prevalence estimates suggesting <1:10,000 1
  • Potentially lethal but highly treatable genetic heart disease 1
  • Associated with ventricular dysfunction and arrhythmias 1

6. Giant Cell Myocarditis (GCM)

  • Extremely rare inflammatory cardiomyopathy 4, 5
  • Characterized by fulminant clinical course with diffuse myocardial necrosis and multinucleated giant cells 5
  • Poor prognosis despite immunosuppressive treatment 4
  • Predominantly CD8+ T-cell response distinguishes it from cardiac sarcoidosis 5

7. Cardiac Sarcoidosis (CS)

  • Rare disorder causing cardiomyopathy with ventricular arrhythmias or heart block 4
  • More indolent presentation than GCM with well-formed nonnecrotizing granulomas 5
  • Prognosis varies according to degree of left ventricular dysfunction 4

Rare Genetic Syndromes with Cardiac Involvement

8. Naxos Disease

  • Prevalence 0-1% among ARVC patients (higher in Naxos, Greece) 1
  • Cardiocutaneous syndrome with autosomal recessive inheritance 1
  • Caused by mutations in plakoglobin (JUP gene) 1

9. Carvajal Syndrome

  • Extremely rare cardiocutaneous condition 1
  • Autosomal recessive inheritance pattern 1
  • Associated with desmosomal protein abnormalities 1

10. TMEM43-Related Arrhythmogenic Cardiomyopathy

  • Prevalence 0-2% of ARVC cases (higher in Newfoundland) 1
  • Canadian (Newfoundland) founder mutation 1
  • Younger male onset with highly lethal ventricular arrhythmias in males 1

Clinical Context and Diagnostic Challenges

These rare diseases share common features that complicate diagnosis and management:

  • Most data derive from registries rather than randomized trials due to small patient populations 1
  • Severity of ECG phenotype generally correlates with sudden cardiac death risk across these conditions 1
  • Long QT syndrome (LQTS) has higher prevalence (approximately 1:2,000) and thus does not qualify among the 10 rarest 1
  • Hypertrophic cardiomyopathy (HCM) has prevalence of approximately 1:500, making it relatively common 1

Important caveat: Many patients with arrhythmogenic cardiomyopathy (36% in recent multinational cohorts) have no detectable pathogenic variant, suggesting additional rare genetic causes remain unidentified 1. This indicates the true spectrum of rare cardiovascular diseases likely extends beyond currently recognized entities.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Arrhythmogenic cardiomyopathy.

Orphanet journal of rare diseases, 2016

Research

Arrhythmogenic right ventricular cardiomyopathy.

Pacing and clinical electrophysiology : PACE, 2009

Related Questions

What are the current management strategies for individuals at risk of or diagnosed with cardiovascular diseases and strokes?
Is a 60-minute completion time for a 1.5-mile swim adequate for a 63-year-old female?
What are the key recommendations in the American Heart Association (AHA) guidelines for cardiovascular care in 2025?
What is the management plan for a patient with angina, hyperlipidemia, arrhythmias, hypertension, chest pain, hypertriglyceridemia, congestive heart failure, peripheral vascular disease, coronary artery disease, valvular disease, and endocarditis?
What are the recommendations of the 2024 American Heart Association (AHA)/American College of Cardiology (ACC) guidelines for managing cardiovascular disease?
How to differentiate and treat scurvy versus osteomyelitis in a child?
What is the recommended duration of ceftriaxone (a third-generation cephalosporin antibiotic) therapy for a patient with a complex clinical presentation, significant neurological compromise, and suspected fungal infection, who has been on ceftriaxone for 9 days without a clear indication of bacterial infection?
What is the recommended duration of amoxicillin oral treatment for an uncomplicated Enterococcus (E.) faecalis infection?
What is the management and treatment for a patient with a thyroid cartilage fracture from trauma?
What are the proper methods for sterilisation and disinfection in a healthcare setting to prevent hospital-acquired infections?
What is the diagnosis and management for a 50-year-old female patient presenting with eye pain, redness, protrusion, diplopia (double vision), and fever of 2 days duration?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.